Health officials are warning a shortage of anti-psychotic drug - olanzapine - could cause relapses for people with schizophrenia symptoms.
Supply of the injected medication is already low, and a shipment didn't arrive last month.
Royal College of Psychiatrists New Zealand chair, Hiran Thabrew, says it's critical for people to get their regular medication, or a substitute.
"What might happen is that people might experience a deterioration in their mental state, they might notice symptoms of psychosis start to occur and people around them might notice their behaviour changing."
LISTEN ABOVE

Nicola Willis: Finance Minister brushes off worries about fast track for housing projects
07:22

Mike Casey: Rewiring Aotearoa CEO on shortage of electricians as solar panel demand soars
05:12

Richard Harrison: Auckland Transport Public Transport Director on CRL first weekday, Warriors this weekend
02:55